BRISTOL-MYERS SQUIBB COMPANY |
Market Closed -
Other stock markets
|
After market 06:59:28 pm | |||
| 44.01 USD | -0.23% |
|
44.02 | +0.03% |
| May. 16 | Everlasting momentum |  |
| May. 16 | Bristol Myers Gets FDA OK of Breyanzi in Follicular Lymphoma | DJ |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes
End-of-day quotes
Sector Other Pharmaceuticals
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
|---|---|---|---|---|---|---|
| 89.42B | - | |||||
| 694B | ||||||
| 593B | ||||||
| 371B | ||||||
| 331B | ||||||
| 290B |
